Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors-induced Bullous pemphigoid

  1. Nieto-Benito, L.M.
  2. Bergón-Sendín, M.
  3. Pulido-Pérez, A.
  4. Suárez-Fernández, R.M.
Revue:
Experimental Dermatology

ISSN: 1600-0625 0906-6705

Année de publication: 2022

Volumen: 31

Número: 4

Pages: 641-642

Type: Lettre

DOI: 10.1111/EXD.14483 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable